首页> 外文OA文献 >DIAGNOSTIC AND THERAPEUTIC ROLE OF THYROID REMNANT ABLATION WITH LOW ACTIVITY OF 131I IN PATIENTS WITH LOW AND INTERMEDIATE RISK PAPILLARY THYROID CARCINOMA (PTC).
【2h】

DIAGNOSTIC AND THERAPEUTIC ROLE OF THYROID REMNANT ABLATION WITH LOW ACTIVITY OF 131I IN PATIENTS WITH LOW AND INTERMEDIATE RISK PAPILLARY THYROID CARCINOMA (PTC).

机译:低和中度风险乳头状甲状腺癌(PTC)患者的131I活性低的甲状腺残留消融的诊断和治疗作用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The real need to perform thyroid residual ablation with 131I (RRA) is nowdays under debate, particularly in patients with low and intermediate risk PTC. \udObjective: In this study we evaluated the diagnostic and therapeutic role of this procedure.\udPatients: To this purpose we analyzed the data of 548 consecutive patients (pts) with PTC treated with total thyroidectomy, arrived at the Department of Endocrinology of Pisa in 2006 to perform RRA. All patients were treated in hypothyroidism with a standard activity of 30 mCi of 131I (1110 MBq) followed by a Whole Body Scan (pWBS). Neck ultrasound and serum thyroglobulin (Tg) and thyroid hormones measurements were performed in all pts. On the basis of TNM we classified patients in two groups: low risk (LR; n=348) and intermediate risk (IR; n=200).\udResults: In addition to the thyroid remnant, the pWBS showed the presence of further areas of 131I uptake in 16/548 (2.9%): 7 LR (2.2%) and 9 IR (4.3%) (p=0.09). The mean value of serum Tg was 86.329+112.398 ng/ml in LR and 242.411+260.779 ng/ml in IR (p=0.1). In 11/16 pts (4 LH, 7 IR) pWBS showed the presence of latero-cervical lymph node metastases, 9 out of 11 were also detected by neck ultrasound followed by fine needle aspiration citology (FNAC). The pWBS showed mediastinal uptake in 1/16 (1 IR), lung metastases in 3/16 (2 LR, 1 IR) and bone metastases in 1/16 (1 LR). Only 7/548 (1.3 %) (5 LR and 2 IR) metastases were detected by pWBS only. At the end of follow-up (median 7.8 years), 8/16 pts were free of disease (5 LR, 3 IR) while the other 8 had persistent disease: 5 “biochemical” disease (1 lung and 4 lymph nodes) and 3 “structural” disease (1 bone, 1 mediastinum and 1 lymph node). Remission was achieved in 3 cases after one single 131I activity, in 1 case after surgical treatment and in the last 4 cases after several 131I courses . \udConclusions: The pWBS after RRA played an important diagnostic role in only 1.3 % of PTC pts with no difference between LR and IR groups. Serum Tg was unable to predict pWBS positive cases. Three out of 3 cases with lung and 8/11 lymphnodes metastases revealed by pWBS have been cured by 131-I. Unfortunately, we do not know what could happen to these subjects, especially those with lung metastases, if the pWBS was not performed.
机译:如今,真正需要使用131I(RRA)进行甲状腺残余消融治疗的争论不断,特别是在中低危PTC患者中。 \ ud目的:在这项研究中,我们评估了该手术的诊断和治疗作用。\ ud患者:为此,我们分析了548例接受全甲状腺切除术治疗的PTC连续患者(pts)的数据, 2006年执行RRA。所有患者均接受甲状腺功能减退症治疗,标准活性为30 mCi 131I(1110 MBq),然后进行全身扫描(pWBS)。所有患者均进行了颈部超声检查和血清甲状腺球蛋白(Tg)和甲状腺激素的测定。根据TNM,我们将患者分为两类:低风险(LR; n = 348)和中度风险(IR; n = 200)。\ ud结果:除了甲状腺残余,pWBS还显示了其他区域16/548(2.9%)中131I摄取的百分比:7 LR(2.2%)和9 IR(4.3%)(p = 0.09)。 LR中的血清Tg平均值为86.329 + 112.398 ng / ml,IR中的血清Tg平均值为242.411 + 260.779 ng / ml(p = 0.1)。在11/16分(4 LH,7 IR)中,pWBS显示存在颈椎淋巴结转移,颈部超声检查以及细针抽吸术(FNAC)还检测出11个淋巴结转移中的9个。 pWBS显示纵隔摄取为1/16(1 IR),肺转移为3/16(2 LR,1 IR),骨转移为1/16(1 LR)。仅pWBS仅检测到7/548(1.3%)(5 LR和2 IR)转移。在随访结束时(中位年龄为7.8年),有8/16分无疾病(5 LR,3 IR),而其他8呈持续性疾病:5例“生化”疾病(1肺和4淋巴结) 3种“结构性”疾病(1骨,1纵隔和1淋巴结)。一次131I活动后3例,手术治疗后1例,多次131I疗程后的最后4例实现了缓解。 \ ud结论:RRA后的pWBS仅在1.3%的PTC pts中发挥了重要的诊断作用,LR组和IR组之间没有差异。血清Tg无法预测pWBS阳性病例。 131-I已治愈pWBS揭示的3例肺和8/11淋巴结转移中的3例。不幸的是,如果不进行pWBS,我们不知道这些受试者会发生什么,特别是那些患有肺转移的受试者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号